Sanjeeb Kumar Sahoo
Overview
Explore the profile of Sanjeeb Kumar Sahoo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Verma P, Mohanty N, Pruseth B, Sahoo S, Katiyar A, Singh H, et al.
Microrna
. 2022 Jul;
11(3):216-226.
PMID: 35786199
Background: The fetus grows in a sterile womb environment. After birth, the newborn immune system has two immediate hurdles to clear. First immediate suppression of the womb compatible immune system...
12.
Singh P, Sahoo S
Int J Pharm
. 2022 Feb;
616:121526.
PMID: 35104598
TNBC exhibits higher rate of chemoresistance, metastasis, and relapse among all subtypes of breast cancer. This malignant statein TNBC is due to self-renewing sub-population of cells called cancer stem cells...
13.
Alam J, Dilnawaz F, Sahoo S, Singh D, Mukhopadhyay A, Hussain T, et al.
Asian Pac J Cancer Prev
. 2022 Jan;
23(1):61-70.
PMID: 35092372
Background: The current disadvantages (high cost, toxicity, resistance) of chemotherapy for gastric cancer opted people for alternative therapy from natural source. Curcumin (natural product) possess multiple biological activities but low...
14.
Singh D, Singh P, Pradhan A, Srivastava R, Sahoo S
ACS Appl Bio Mater
. 2022 Jan;
4(4):3670-3685.
PMID: 35014452
Cancer stem-like cells (CSCs) have emerged as an important target for breast cancer therapy owing to their self-renewability, proliferation, and elevated chemoresistance properties. Here, we present a strategy of eliminating...
15.
Singh D, Mohapatra P, Kumar S, Behera S, Dixit A, Sahoo S
Toxicol In Vitro
. 2021 Dec;
79:105293.
PMID: 34883246
Pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis and remains highly aggressive despite current advancements in therapies. Chemoresistance and high metastatic nature of PDAC is attributed to a small...
16.
Mandal M, Sahoo S, Patra P, Mallik S, Zhao Z
BMC Bioinformatics
. 2020 Dec;
21(Suppl 21):499.
PMID: 33371879
Background: Cancer stem cells (CSCs) have features such as the ability to self-renew, differentiate into defined progenies and initiate the tumor growth. Treatments of cancer include drugs, chemotherapy and radiotherapy...
17.
Mohapatra P, Singh P, Sahoo S
Drug Discov Today
. 2020 Jun;
25(8):1307-1321.
PMID: 32554061
Research suggests that tumor relapse and metastasis is caused by minor population of tumor-initiating cells called cancer stem cells (CSCs), which exhibit self-renewability, quiescence, antiapoptosis, and drug resistance. Conventional chemotherapeutics...
18.
Singh A, Jain S, Sahoo S
Mater Sci Eng C Mater Biol Appl
. 2020 Mar;
110:110695.
PMID: 32204010
Targeted cancer therapy facilitates localizing the action of chemotherapeutic drugs at the tumor site enhancing the therapeutic efficacy and reducing the side effects to the healthy cells. The homing property...
19.
Singh D, Dilnawaz F, Sahoo S
Nanomedicine (Lond)
. 2020 Jan;
15(2):111-114.
PMID: 31903854
No abstract available.
20.
Arya G, Das M, Sahoo S
Biomed Pharmacother
. 2018 Mar;
102:555-566.
PMID: 29597089
Pancreatic cancer is considered as one of the most lethal type of cancer with a poor 5-year survival rate. Cancer metastasis represents one of the primary cause which limits therapy...